Results 201 to 210 of about 9,490,238 (346)

Solid-phase biological assays for drug discovery.

open access: yesAnnual Review of Analytical Chemistry, 2014
E. Forsberg, C. Sicard, John D. Brennan
semanticscholar   +1 more source

Annual Report - Marine Biological Laboratory, 1921

open access: yes, 1921
Annual report of the Marine Biological Laboratory in Woods Hole. 1921.
Marine Biological Laboratory (Woods Hole MA)
core  

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Annual Report - Marine Biological Laboratory, 1924

open access: yes, 1924
Annual report of the Marine Biological Laboratory in Woods Hole. 1924.
Marine Biological Laboratory (Woods Hole MA)
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Annual Report - Marine Biological Laboratory, 1945

open access: yes, 1946
Annual report of the Marine Biological Laboratory in Woods Hole. 1945.
Marine Biological Laboratory (Woods Hole MA)
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy